Document Type
Article
Rights
Available under a Creative Commons Attribution Non-Commercial Share Alike 4.0 International Licence
Disciplines
Biology, Medical engineering
Abstract
Mechanisms underlying the in vitro cytotoxicity of Polyamidoamine nano-dendrimers in human keratinocytes are explored. Previous studies demonstrated a systematic, dendrimer-generation-dependent cytotoxicity, oxidative stress, and genotoxicity. The emerging picture is of dendrimer endocytosis, endosomal rupture and subsequent mitochondrial attack and cell death. To understand the underlying mechanisms, the evolution of reactive oxygen species, intracellular glutathione, caspase activation, mitochondrial membrane potential decay, and inflammatory responses have been examined. Early-stage responses are associated with endosomal encapsulation, later-stage with mitochondrial attack. In all cases, the magnitude and evolution of responses depend on dendrimer generation and dose. The early-stage response is modelled using a rate equation approach, qualitatively reproducing the time, dose and generation dependences, using only two variable parameters. The dependence of the response on the nanoparticle physicochemical properties can thus be separated from internal cellular parameters, and responses can be quantified in terms of rate constants rather than commonly employed effective concentrations.
DOI
https://doi.org/10.1016/j.nano.2012.05.002
Recommended Citation
Mukherjee, S.P., Byrne, H.J., 2012. Polyamidoamine dendrimer nanoparticle cytotoxicity, oxidative stress, caspases activation and infammatory response: experimental observation and numerical simulation. Nanomedicine: Nanotechnology, Biology, and Medicine, 9, 202-211 (2013) doi:10.1016/j.nano.2012.05.002
Funder
This work was conducted under the framework of the INSPIRE programme, funded by the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013, supported by the European Union Structural Fund.
Publication Details
Nanomedicine: Nanotechnology, Biology and Medicine; DOI: 10.1016/j.nano.2012.05.002.